Curve Therapeutics
PrivateLast Round
Series A
Feb 27, 2024
Total Funding Raised
$62.92M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Curve Therapeutics is a biotechnology company that develops a drug discovery platform for creating macrocycle-derived therapeutics to treat cancer, immunology, and inflammation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curve Therapeutics Comparables
Compare Curve Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orbis Medicines | 88% | |
| BRT Biotechnologies | 86% | |
| Insamo | 84% |
Curve Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 27, 2024 | ||||
| Seed | Jul 31, 2020 | ||||
| Seed | Jun 27, 2019 |
Curve Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Epidarex Capital | Seed, Series A |
| Advent Life Sciences | Series A, Seed |
| British Patient Capital | Series A |
| British Patient Capital | Series A |
| Pfizer Ventures | Series A |
| Pfizer | Series A |
| Columbus Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 225% MoM.
- Jun 25, 2025
Co-Founder recognized with the Interdisciplinary Prize by the Royal Society of Chemistry.
Curve Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Curve Therapeutics's valuation, stock price, and market status.
Is Curve Therapeutics a public or private company?
Curve Therapeutics is a private company.
What is the current stock price of Curve Therapeutics?
Curve Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Curve Therapeutics worth (valuation)?
Valuation information for Curve Therapeutics is not publicly available.
Can I buy Curve Therapeutics stock?
Curve Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Curve Therapeutics's last funding round?
Curve Therapeutics's most recent funding round was Series A on February 27, 2024.
Who are the main investors in Curve Therapeutics?
Key investors in Curve Therapeutics include Epidarex Capital, Advent Life Sciences, Pfizer Ventures, Pfizer, Columbus Venture Partners.
Will Curve Therapeutics IPO soon?
No public IPO plans have been announced for Curve Therapeutics.
How can I track Curve Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Curve Therapeutics's secondary market activity and sign up for updates.